Kymera Therapeutics, Inc.KYMRNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Above historical average.
Left:
||||
Price-to-book ratio
Latest
3.61
↑ 169% above average
Average (6y)
-5.20
Historical baseline
Range
High:9.73
Low:-43.01
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 3.61 | -4.0% |
| 2023 | 3.76 | +37.0% |
| 2022 | 2.75 | -58.6% |
| 2021 | 6.63 | -31.9% |
| 2020 | 9.73 | +148.9% |
| 2019 | -19.91 | +53.7% |
| 2018 | -43.01 | - |